Company intelligence / Profile preview

StelKast

McMurray, Pennsylvania, United Statesecosystem.madrimasd.org ↗

Ownership: Private
Development stage: Commercial

Overview

StelKast developed and commercialized orthopedic implants for hip and knee replacements. Its EXp™ technology—a blend of antioxidant vitamin E with highly cross-linked polyethylene—was the first of its kind in the U.S. for hip replacements and later expanded to knee systems. The company’s Proven Gen-Flex™ Total Knee System received FDA 510(k) clearance in 2013. The company was acquired by Globus Medical in September 2019.

Therapeutic areas: Rheumatology
Modalities: Device (orthopedic implants)Polymer-based implant materials (e.g., cross-linked polyethylene)
Industry: Implantable Medical Devices

Partnerships

Historically supplied major orthopedic companies as a contract manufacturer before developing its own branded products

Beyond the preview

Go deeper on StelKast.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on StelKast.

Explore the full profile